Fournier-Majoie
VC Fund
Brussels, Belgium
Fournier-Majoie is a VC fund in Brussels focused on Biotechnology and Health Care. Fournier-Majoie Foundation is a non-profit organization whose mission is to identify, support and guide promising researchers.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Fournier-Majoie invests in
Stages Fournier-Majoie invests in
Countries Fournier-Majoie invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Investment Focus
Industry
- Biotechnology 4 (100%)
- Health Care 2 (50%)
- Pharmaceutical 2 (50%)
- Medical 1 (25%)
- Oncology 1 (25%)
Stage
- Seed 3 (75%)
- Venture - Series Unknown 1 (25%)
Country
- France 2 (50%)
- Austria 1 (25%)
- Belgium 1 (25%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Bernard Majoie
President
|
President | Total investments: 6 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development. | $3.5M / Venture - Series Unknown / Mar 12, 2026 | |
|
|
Hephaistos Pharma is a developing weapons firm. They provide services for oncology, immunotherapy, and cancer. An online inquiry form is available on the company's website. | $4.9M / Seed / Jan 23, 2024 | |
|
|
Mablink Bioscience is a biotechnology company specialized in the development of a new class of cancer drugs, called Antibody Drug Conjugate (ADC). | $4.8M / Seed / Apr 27, 2021 | |
|
|
ATB Therapeutics is a biopharmaceutical company that provides novel therapeutic solutions and treatments for cancer patients. | Seed |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Fournier-Majoie invest in?
Fournier-Majoie invests primarily in Biotechnology, Health Care and Pharmaceutical startups, most often at Seed and Venture - Series Unknown stage. Most of the 4 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Fournier-Majoie?
Public channels for Fournier-Majoie include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Fournier-Majoie?
The team at Fournier-Majoie includes Bernard Majoie (President). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!